Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency129
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea96
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value64
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia41
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran40
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique37
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study35
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial25
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis23
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model21
The relative cost-effectiveness of atraumatic needles compared to conventional needles in diagnostic lumbar punctures20
Economic burden of knee joint replacement in Iran19
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening19
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi17
Benefit-cost analysis of nonprofit cataract surgery services in Latin America: a multinational evaluation through an SROI lens17
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model17
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”17
0.11111903190613